The Daily FWD presents...
Editor’s Note: At The Daily FWD we’re always looking out for special opportunities we believe you, as a valued subscriber, will want to see. Below you’ll find one from our partners at The Oxford Club. Please note that their opinions may differ from ours. The perfect AI stock under $10 Dear Reader, If you’re looking for a great AI stock under $10... you need to watch this right away.
What the company is doing is pretty incredible. It could end up saving billions of lives... and billions of dollars.
In short, the company is the creator of the first AI-designed drug to enter clinical trials.
And this is a huge deal.
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion.
However, new AI technology has the potential to make the process up to 1000 times faster.
The Wall Street Journal reports that "the time required for the early stages of drug discovery could shrink from years to months."
Not only that, it has the potential to develop "never-before-seen molecules that could treat diseases like pancreatic cancer or ALS."
In short, this is groundbreaking stuff.
And this #1 AI company is at the forefront of all of it.
The biggest pharmaceutical companies in the world are lining up to work with them.
For example... - Merck is collaborating with them on three projects that could generate up to $674 million in revenue.
- French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs.
- Bristol Meyers Squibb signed a $1.2 billion partnership with the company.
And yet... the company I’m talking about is valued at just over $500 million today. And it trades for less than $10.
In other words, these deals have the potential to drive the stock many times higher in the months and years ahead.
So again, if you’re looking for a great AI stock to own, you need to watch this presentation right away. | | | P.S. The best way to play this AI stock involves an investment strategy used by a Kansas welder to become one of the wealthiest people in the world.
See his incredible investment approach here.
Sincerely,
Rachel Gearhart
Publisher, The Oxford Club | |
| | | | © 2024 Paradigm Press, LLC. 1001 Cathedral Street, Baltimore, MD 21201. By submitting your email address, you consent to Paradigm Press, LLC. delivering daily email issues and advertisements. To end your The Daily FWD e-mail subscription and associated external offers sent from The Daily FWD, feel free to click here. Please note: the mailbox associated with this email address is not monitored, so do not reply to this message. We welcome comments or suggestions at feedback@paradigmpressgroup.com. This address is for feedback only. For questions about your account or to speak with customer service, contact us here or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. The Daily FWD is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our Privacy Statement. If you are having trouble receiving your The Daily FWD subscription, you can ensure its arrival in your mailbox by whitelisting The Daily FWD. | | |
No comments:
Post a Comment
Keep a civil tongue.